Search Results - "AREMAN, E. M"

Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer by MEEHAN, K. R, ARUN, B, GEHAN, E. A, BERBERIAN, B, SULICA, V, AREMAN, E. M, MAZUMDER, A, LIPPMAN, M. E

“…We previously demonstrated findings suggestive of autologous GVHD in patients receiving IL-2-activated peripheral blood stem cells (PBSC) with IL-2 after…”
Get full text

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer : Investigation of dose level with clinical correlates by MEEHAN, K. R, VERMA, U. N, MAZUMDER, A, CAHILL, R, FRANKEL, S, AREMAN, E. M, SACHER, R. A, FOELBER, R, RAJAGOPAL, C, GEHAN, E. A, LIPPMAN, M. E

“…Incubating hematopoietic stem cells with IL-2 in vitro for 24 h generates cytotoxic T cells. When infused into patients, these cells may stimulate a…”
Get full text

Preapheresis levels of peripheral blood CD34+ cells correlate with CD34+ peripheral blood progenitor cells in autologous patients by Areman, Ellen M., Meehan, Kenneth R., Sacher, Ronald A.

Get full text

Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients by Areman, E M, Mazumder, A, Kotula, P L, Verma, U N, Rajagopal, C, Hancock, S, Guevarra, C, Djahanmir, M, Sacher, R A, Meehan, K R

“…Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving…”
Get more information

Processing and storage of human bone marrow: a survey of current practices in North America by Areman, E M, Sacher, R A, Deeg, H J

“…We conducted a two-step survey to question 110 transplant centers in the United States and Canada regarding marrow processing and storage policies and…”
Get more information

Use of a licensed electrolyte solution as an alternative to tissue culture medium for bone marrow collection by Areman, E M, Dickerson, S A, Kotula, P L, Spitzer, T R, Sacher, R A

“…Bone marrow for transplantation is traditionally collected into tissue culture medium with heparin. A licensed electrolyte solution (Plasma-Lyte A [PLA]) was…”
Get more information

A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application by Charak, B S, Areman, E M, Dickerson, S A, Choudhary, G D, Sacher, R, Kotula, P L, Brown, E G, Mazumdar, A

“…Interleukin-2 (IL-2) activation of fresh or frozen bone marrow (BM) in vitro generates killer cells with potent anti-tumor effect both in vitro and in vivo…”
Get more information

Automated processing of human bone marrow can result in a population of mononuclear cells capable of achieving engraftment following transplantation by Areman, E M, Cullis, H, Spitzer, T, Sacher, R A

“…A concentrate of mononuclear bone marrow cells is often desired for ex vivo treatment with pharmacologic agents, monoclonal antibodies, cytokines, and other…”
Get more information

Bulk cryopreservation of lymphocytes in glycerol by Areman, E M, Simonis, T B, Carter, C S, Read, E J, Klein, H G

“…The authors describe a method for freezing large amounts of peripheral blood lymphocytes (PBL) in a 20 percent glycerol solution. Between 0.6 and 4.3 X 10(9)…”
Get more information

Cryopreservation and storage of human bone marrow: a survey of current practices by Areman, E M, Sacher, R A, Deeg, H J

“…As bone marrow transplantation is being used with increasing frequency, problems of storage space and cost, inventory control and disposal have arisen. Issues…”
Get more information

Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs by Meehan, K R, Areman, E M, Ericson, S G, Matias, C, Seifeldin, R, Schulman, K

“…We surveyed five academic medical centers to develop a clinical process for patients undergoing cytokine mobilization and leukapheresis prior to autologous…”
Get more information

Automated isolation of mononuclear cells using the Fenwal CS3000 blood cell separator by Areman, E M, Cullis, H, Sacher, R A, Cottler-Fox, M, Deeg, H J

“…We describe a method for in vitro isolation of mononuclear cells from peripheral blood or bone marrow using a Fenwal CS3000 Apheresis device without employing…”
Get more information

Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignancies by Areman, E M, Rhodes, P L, Mazumder, A, Meehan, K R

“…Culturing of hematopoietic progenitor cells for 24 h with IL-2 generates cytotoxic effector cells that mediate in vitro and possibly in vivo antitumor…”
Get more information

In vitro activation of peripheral blood stem cells with interleukin-2 by Verma, U N, Areman, E M, Sacher, R A, Mazumder, A

Get more information

Use of licensed electrolyte solutions and anticoagulant citrate dextrose for bone marrow collection by Areman, E M, Dickerson, S A, Bender, J G, Cullis, H, Sacher, R A

Get more information

Bone marrow storage and processing: is it time to set standards? by Areman, E M, Sacher, R A, Deeg, H J

Get more information

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait by Kang, Elizabeth M., Areman, Ellen M., David-Ocampo, Virginia, Fitzhugh, Courtney, Link, Mary E., Read, Elizabeth J., Leitman, Susan F., Rodgers, Griffin P., Tisdale, John F.

“…Mobilized peripheral blood is increasingly used as the source of hematopoietic stem cells for allogeneic transplantation, currently the only curative approach…”
Get full text

Bone marrow processing for transplantation by Areman, E M, Sacher, R A

“…As indications for BMT increase, so do variations in bone marrow processing and manipulation techniques. Many centers have their own unique methods of…”
Get more information

Processing and storage of human bone marrow: do we know enough to set guidelines, standards, and regulations? by Areman, E M, Cottler-Fox, M

Get more information

The impact of harvest center on quality of marrows collected from unrelated donors by Spitzer, T R, Areman, E M, Cirenza, E, Yu, M, Dickerson, S, Kotula, P L, Sacher, R A, Cottler-Fox, M

“…The total number and distribution of nucleated cells in harvested bone marrow are potentially important determinants of patient outcome following bone marrow…”
Get more information